An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)

類似資料

• An audit of the approval letters issued by Drugs Controller General of India to Ethics Committees in India
  著者:: Bhide, Shruti S., 等
  出版事項: (2016)
• Investigator-initiated studies: Challenges and solutions
  著者:: Konwar, Mahanjit, 等
  出版事項: (2018)
• The global initiative for asthma guidelines (2019): change in the recommendation for the management of mild asthma based on the SYGMA-2 trial – A critical appraisal
  著者:: Rajan, Sujeet, 等
  出版事項: (2020)
• Current status of standardized, quality and ethical oversight of clinical research in the country: An audit of the Central Drugs Standard Control Organization (registration of ethics committees) and national accreditation board for hospital and healthcare providers (accreditation) databases
  著者:: Nishandar, Tushar Bhimrao, 等
  出版事項: (2019)
• An analysis of completeness and quality of adverse drug reaction reports at an adverse drug reaction monitoring centre in Western India
  著者:: Mahajan, Manali Mangesh, 等
  出版事項: (2018)